Creating tiny needles for painless eye drug delivery

Development of Nanoneedle Array for Painless and Long-Term Sustained Intraocular Drug Delivery

NIH-funded research Purdue University · NIH-10903778

This study is testing a new, tiny needle system that can deliver medicine directly to the eye through a special contact lens, making it easier and more comfortable for people with corneal neovascularization to get the treatment they need to help prevent vision loss.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPurdue University NIH-funded
Lab location1 site (West Lafayette, United States)
Project IDNIH-10903778 on NIH RePORTER

What this research studies

This research focuses on developing a new type of nanoneedle array designed for painless and long-term delivery of medication directly to the eye. By utilizing fully-miniaturized silicon nanoneedles that are significantly smaller than current options, the project aims to enhance the effectiveness of treatments for corneal neovascularization, a condition that can lead to blindness. The nanoneedles will be integrated into a water-soluble contact lens, allowing for rapid degradation and optimal fit for various corneal shapes, thereby improving patient comfort and therapeutic outcomes.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals suffering from corneal neovascularization or related eye conditions that require sustained drug delivery.

Not a fit: Patients with conditions unrelated to corneal neovascularization or those who do not require intraocular drug delivery may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide a more effective and comfortable method for delivering medications to the eye, potentially reducing the risk of blindness.

How similar studies have performed: Previous research has shown promise with biodegradable microneedles for drug delivery, but this approach using nanoscale needles is relatively novel.

Where this research is happening

West Lafayette, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cellular injury
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.